Josh Blair's Trading History
| EXEExtendicare | May 15, 2026 | Director | Informative Buy | 346.65K | C$265.70K | |
| CGYCalian Group | Dec 24, 2025 | Director | Uninformative Sell | 54.03K | C$492.98K | |
| TIXTTELUS International (CDA) | Apr 01, 2025 | ― | Uninformative Sell | 34.01K | $828.58K | |
| CRBKCarebook Technologies Inc | May 20, 2022 | ― | Informative Buy | 30.00K | C$38.00K | |
| NBLYNeighbourly Pharmacy, Inc. | May 27, 2021 | ― | Informative Buy | 499.80K | C$546.84K | |
| TUTelus | Dec 16, 2019 | Divisional Executive Vice-President | Informative Buy | ― | $1.83M |
You May Also Like
Josh Blair insider profile FAQ
What is the percentage of profitable transactions made by Josh Blair?
The percentage of profitable transactions made by Josh Blair is 56%.
What is the average return per transaction made by Josh Blair?
The average return per transaction made by Josh Blair is 5.90%.
What stocks does Josh Blair hold?
Josh Blair holds: TSE:EXE, TU, TSE:CGY, TSE:CRBK, TIXT, TSE:NBLY stocks.
What was Josh Blair’s latest transaction?
Josh Blair’s latest transaction was an Informative Buy of C$346.65K.
What was Josh Blair's most profitable transaction?
Josh Blair’s most profitable transaction was an Informative Buy of TSE:CGY stock on February 19, 2025. The return on the trade was 78.30%.
What is Josh Blair's role in Extendicare?
Josh Blair's role in Extendicare is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.
TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.